Edwards Lifesciences Corp is 39.2x more valuable than Cadre Holdings, Inc. by market capitalization ($49.51 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CDRE | EW |
|---|---|---|
| Market cap | $1.26 B | $49.51 B |
| US-listed rank | #2461 | #320 |
| Revenue (latest FY) | $610.31M | $6.07B |
| Net income (latest FY) | $44.14M | $1.07B |
| Net margin | 7.2% | 17.7% |
| P/E (trailing FY) | 28.6 | 46.1 |
| SEC filings | 380 | 2,569 |
Edwards Lifesciences Corp is 39.2x more valuable than Cadre Holdings, Inc. by market capitalization ($49.51 B vs $1.26 B).
In their latest fiscal years, Cadre Holdings, Inc. reported $610.31M in revenue while Edwards Lifesciences Corp reported $6.07B.
Full pages: Cadre Holdings, Inc. and Edwards Lifesciences Corp, or browse the full rankings.